In early 2026, the pharmaceutical industry is increasingly utilizing "lock-and-key" activation systems to pair specific drug formulations with customized vibrating mesh nebulizers. These 2026 systems ensure that a particular medication is only delivered through a device that has been optimized for its specific viscosity and surface tension, guaranteeing the intended aerosol characterization. In...

We are witnessing a seismic shift in 2026 as "Digital Therapeutics" (DTx) move into the mainstream of the Software as a Medical Device (SaMD) Market. These are clinically validated software programs designed to treat, manage, or prevent medical disorders. From FDA-cleared apps for ADHD to software-led cognitive behavioral therapy for chronic insomnia, DTx are proving that code can be just as...